Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ARG2 | P78540 | 1/20 | 0.40 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4155331 | 0.81 | MAOB (0.48) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL3295095 | 0.81 | MAOB (0.48) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL8174260 | 0.81 | MAOB (0.48) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL5680524 | 0.79 | MAOB (0.46) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL15365066 | 0.79 | MAOB (0.46) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL11098509 | 0.79 | SIGMAR1 (0.50) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL794180 | 0.79 | MAOB (0.46) | MAOBTAAR1SIGMAR1SLC6A2SLC6A4 | |
| SCHEMBL10902102 | 0.78 | IDO1 (0.42) | MAOBTAAR1MAOACYP2A6TP53 | |
| SCHEMBL11658046 | 0.78 | CYP1A2 (0.45) | SIGMAR1CYP2D6 | |
| SCHEMBL11547165 | 0.78 | PTGES (0.48) | MAOBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106608939-B | The preparation method of catalytic component for olefinic polymerization | 中国石油化工股份有限公司 | 2019-08-20 | — | — | CN | claimed |
| CN-110099930-A | modified conjugated diene polymer and preparation method thereof | 株式会社LG化学 | 2019-08-06 | — | — | CN | claimed |
| CN-106608940-B | The preparation method of catalytic component for olefinic polymerization | 中国石油化工股份有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-104558290-B | One kind being used for catalyst component for olefin polymerization and catalyst | 中国石油化工股份有限公司 | 2018-11-02 | — | — | CN | claimed |
| CN-104558291-B | One kind is used for olefin polymerization catalysis preparation method | 中国石油化工股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-104558292-B | One kind is used for olefin polymerization catalysis preparation method | 中国石油化工股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106608939-A | Preparation method of catalyst component for olefin polymerization | 中国石油化工股份有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-106608940-A | Preparation method for catalyst components used for olefin polymerization | 中国石油化工股份有限公司 | 2017-05-03 | — | — | CN | claimed |
| CN-104558293-B | Catalyst component for olefin polymerization and catalyst | 中国石油化工股份有限公司 | 2017-02-15 | — | — | CN | claimed |
| US-20130040917-A1 | Phenazopyridine Compounds | PINNACLE PHARMACEUTICALS, INC. (US) | 2013-02-14 | — | — | US | claimed |
| EP-0812839-A1 | Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof | LG Chemical Limited (KR) | 1997-12-17 | — | — | EP | claimed |
| US-5670517-A | MULTISTAGE SYNTHESIS WITH EPOXIDATION, DECARBONYLATION, COUPLING BY AMIDATION THEN DECARBONYLATION | LG CHEMICAL LIMITED (KR) | 1997-09-23 | — | — | US | claimed |
| WO-2024129756-A1 | SITE-SPECIFIC ENGINEERED CYSTEINE ANTIBODY DRUG CONJUGATES | SEAGEN INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| CN-110968218-B | Touch display panel and preparation method thereof | 合肥维信诺科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-2024036329-A2 | CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF | SEAGEN INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| WO-2023178289-A2 | CAMPTOTHECIN CONJUGATES | SEAGEN INC. (US) | 2023-09-21 | — | — | WO | disclosed |
| US-4343732-A | HEAT AND WEATHER RESISTANCE, BISPHENOL PHOSPHATE STABILIZER | AJINOMOTO COMPANY INCORPORATED (JP) | 1982-08-10 | — | — | US | disclosed |
| EP-0049120-A1 | Phenethylether derivatives, process for preparing same and uses thereof in combatting tobacco beetles and in augmenting or enhancing the aroma of perfumes, colognes and perfumed articles | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1982-04-07 | — | — | EP | disclosed |
| EP-0024897-A2 | Chromogen solutions and pressure-sensitive mark-recording systems | MONSANTO EUROPE S.A./N.V. (BE) | 1981-03-11 | — | — | EP | disclosed |
| US-4136100-A | BLUE-VIOLET TO GREEN-BLUE DYEINGS ON CELLULOSE TEXTILES | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040917-A1 | Phenazopyridine Compounds | CYP3A5, CYP3A4, CYP2D6 | MAOB 264/4885TAAR1 851/4885SIGMAR1 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.